Detalhe da pesquisa
1.
Diabetic Ketoacidosis and Long-term Insulin Requirements in Youths with Newly Diagnosed Type 2 Diabetes During the SARS-CoV-2 Pandemic.
Endocr Pract
; 29(10): 754-761, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451650
2.
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
Endocr Pract
; 29(5): 305-340, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37150579
3.
Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.
Diabetes Obes Metab
; 24(1): 42-49, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490700
4.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Endocr Pract
; 28(10): 923-1049, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963508
5.
Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
Diabetes Obes Metab
; 23(6): 1351-1360, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591621
6.
Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial.
Diabetes Obes Metab
; 23(2): 480-488, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140566
7.
Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes.
Endocr Pract
; 26(7): 722-728, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471640
8.
Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
Diabetes Obes Metab
; 21(4): 837-843, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30456796
9.
THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.
Endocr Pract
; 24(6): 556-564, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29949432
10.
Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).
Curr Diab Rep
; 17(5): 33, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28364357
11.
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
Endocr Pract
; 23(8): 971-978, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28534682
12.
National Strategies to Decrease the Burden of Diabetes and Its Complications.
Curr Diab Rep
; 15(9): 65, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255260
13.
COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
Endocr Pract
; 21(12): 1333-43, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26307899
14.
Glycemic Control During Gender-Affirming Therapy in a Patient With Type 1 Diabetes.
Clin Diabetes
; 37(4): 398-400, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31660018
15.
Estimation of glucose absorption, insulin sensitivity, and glucose effectiveness from the oral glucose tolerance test.
J Clin Endocrinol Metab
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739548
16.
Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Diabetes Care
; 47(2): 267-271, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085705
17.
Continuous Glucose Monitoring-Guided Insulin Administration in Long-Term Care Facilities: A Randomized Clinical Trial.
J Am Med Dir Assoc
; 25(5): 884-888, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460943
18.
Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome.
Hum Reprod
; 28(3): 770-6, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23257395
19.
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1.
Endocrinol Metab Clin North Am
; 52(1): 27-38, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754495
20.
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2.
Endocrinol Metab Clin North Am
; 52(1): 39-47, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754496